Details for Gardasil 9 vaccine and its components.
Registered for use in females aged 9 to <46 years and males aged 9 to <27 years.
9vHPV — Recombinant protein particulate (VLP) vaccine containing the major capsid (L1) protein of HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 30 µg HPV-6 L1 protein
- 40 µg HPV-11 L1 protein
- 60 µg HPV-16 L1 protein
- 40 µg HPV-18 L1 protein
- 20 µg HPV-31 L1 protein
- 20 µg HPV-33 L1 protein
- 20 µg HPV-45 L1 protein
- 20 µg HPV-52 L1 protein
- 20 µg HPV-58 L1 protein
- 0.78 mg L-histidine
- 50 µg polysorbate 80
- 35 µg sodium borate
- residual traces (<7 µg) of yeast protein
All HPV proteins are adsorbed onto 500 µg of aluminium as aluminium hydroxyphosphate sulfate.
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/gardasil-9.